Radiant InnovationROCO:3373 67 PB Ratio is 0.99 as of Jul. 12, 2026, which is 15% below its 10-year median of 1.16. GuruFocus rates ROCO:3373 with a GF Score™ of 67/100 and a GF Value™ of NT$16.69 (Fairly Valued). The stock has 2 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Radiant Innovation ranks better than 79.44% on this metric.
Radiant Innovation Inc stock PB Ratio (=0.99) is close to 2-year low of 0.94.
The historical rank and industry rank for Radiant Innovation's PB Ratio or its related term are showing as below:
ROCO:3373'
s PB Ratio Range Over the Past 10 Years
Min: 0.83 Med: 1.16 Max: 7.78
Current: 0.99
During the past 13 years, Radiant Innovation's highest PB Ratio was 7.78. The lowest was 0.83. And the median was 1.16.
ROCO:3373's PB Ratio is ranked better than 79.44% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.065
vs ROCO:3373: 0.99
During the past 12 months, Radiant Innovation's average Book Value Per Share Growth Rate was -8.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -8.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -9.20% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 3.30% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Radiant Innovation was 26.20% per year. The lowest was -11.70% per year. And the median was -1.00% per year.
Back to Basics: PB Ratio
Radiant Innovation (ROCO:3373) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Radiant Innovation PB Ratio Related Terms
Radiant Innovation PB Ratio Historical Data
* Premium members only.
The historical data trend for Radiant Innovation's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Radiant Innovation's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Radiant Innovation PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Radiant Innovation's PB Ratio distribution charts can be found below:
* The bar in red indicates where Radiant Innovation's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Radiant Innovation (ROCO:3373) has a PB Ratio of 0.99 as of Jul. 12, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Radiant Innovation and its competitors. This is 15% below median its historical median of 1.16. Over the past decade, Radiant Innovation's PB Ratio has ranged from 0.83 to 7.78. According to the industry distribution chart, Radiant Innovation ranks #162 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 20.6%.
Is Radiant Innovation's PB Ratio too high?
Radiant Innovation's current PB Ratio of 0.99 is 15% below median its 10-year median of 1.16. Over the past 10 years, this metric has ranged from a low of 0.83 to a high of 7.78. The Medical Devices & Instruments industry median PB Ratio is 2.07. Radiant Innovation's value of 0.99 is 52.1% below this industry median. Based on the distribution chart, Radiant Innovation ranks #162 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Radiant Innovation has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Radiant Innovation's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Radiant Innovation ranks #162 out of 788 companies for PB Ratio. This places Radiant Innovation in the top 21% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.07. Radiant Innovation's value of 0.99 is 52.1% below this benchmark. Historically, Radiant Innovation's own PB Ratio has ranged from 0.83 to 7.78 over the past decade. While the company's 10-year median is 1.16 vs. the industry median of 2.07, Radiant Innovation has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.07, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Radiant Innovation's current PB Ratio of 0.99 is 52.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Radiant Innovation and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Radiant Innovation's current PB Ratio is 0.99, which is 15% below median its own 10-year median of 1.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Radiant Innovation stock overvalued right now?
Based on GuruFocus' analysis, Radiant Innovation (ROCO:3373) is currently considered Fairly Valued. The stock's GF Value™ is NT$16.69, compared to a current price of NT$16.55 — trading 0.8% below its estimated fair value. The current PB Ratio is 0.99, which is 15% below median its 10-year median of 1.16 and 52.1% below the Medical Devices & Instruments industry median of 2.07. Radiant Innovation's overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Radiant Innovation (ROCO:3373), the current PB Ratio is 0.99 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Radiant Innovation (ROCO:3373) Overvalued in 2026?
Based on GuruFocus' analysis, Radiant Innovation stock appears to be undervalued.
The current stock price of NT$16.55 is trading 0.8% below its estimated GF Value™ of NT$16.69.
GuruFocus considers Radiant Innovation to be Fairly Valued.
Key valuation signals for ROCO:3373:
PB Ratio: 0.99 (15% below median its 10-year median of 1.16)
GF Value™: NT$16.69 vs. price of NT$16.55 (0.8% below fair value)
Industry Position: 52.1% below the Medical Devices & Instruments median (#162 of 788)
No single metric tells the full story. See the ROCO:3373 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Radiant Innovation Inc is engaged in the manufacture and distribution of medical instruments in Taiwan. It provides infrared ear thermometers, multi-function thermometers, infrared forehead thermometers as well as carbon dioxide detectors.
67GF Score
Get the complete analysis for ROCO:3373
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:3373 has been successfully added to your 
